Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05937672 · ClinicalTrials.gov registry record · Phase 3
Cold Atmospheric Plasma Device Extension Study
A Phase 3 study of Verruca Vulgaris and Molluscum Contagiosum, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05937672 is a Phase 3 study of Verruca Vulgaris and Molluscum Contagiosum that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05937672, a Phase 3 study of Verruca Vulgaris and Molluscum Contagiosum, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients between 4-21 years of age with at least one wart or molluscum lesion are eligible to participate in this study. The duration of the study is a minimum of 4 weeks with the maximum duration of monthly treatments for one year, depending on lesion clearance. The number of lesions will be chosen by the dermatologist. Patients who opt to participate will receive non-thermal, or cold, atmospheric plasma to treat all lesions selected. Safety profile as well as changes in size, pain and appearance will be measured. Photographs and dermatologist impressions will be used to measure treatment response.
Conditions Studied
Interventions
- DEVICE Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP)
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-09-18 |
| Est. Completion | 2026-02-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05937672
The ClinicalTrials.gov registry entry for NCT05937672 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Verruca Vulgaris appearing as the primary indexed condition, and to 1 intervention - of which Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP) is the first listed.
NCT05937672 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT05937672 about?
NCT05937672 is a clinical study titled "Cold Atmospheric Plasma Device Extension Study". Patients between 4-21 years of age with at least one wart or molluscum lesion are eligible to participate in this study. The duration of the study is a minimum of 4 weeks with the maximum duration of monthly treatments for one year, depending on lesion clearance. The number of lesions will be chosen...
What is the current status of trial NCT05937672?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2023-09-18. Estimated completion is 2026-02-01.
What conditions does trial NCT05937672 study?
This clinical trial studies the following conditions: Verruca Vulgaris, Molluscum Contagiosum.
What interventions are being tested in trial NCT05937672?
The interventions under investigation include: Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP) (DEVICE).
Who is sponsoring clinical trial NCT05937672?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05937672 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Verruca Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.